BioMarin Pharmaceutical Inc. buy Raymond James
Start price
10.10.24
/
50%
€63.66
Target price
10.10.25
€72.21
Performance (%)
-28.37%
End price
11.10.25
€45.60
Summary
This prediction ended on 11.10.25 with a price of €45.60. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.37%. Raymond_James has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.486% | -4.486% | -11.955% |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
Comments by Raymond_James for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $79.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Current prediction by Raymond_James for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.00
03.09.25
03.09.25
€73.07
03.09.26
03.09.26
-8.16%
15.04.26
15.04.26
